A sutdy for analyzing causative genes for common diseases in urinary tract and male sex organs
泌尿道及男性性器官常见疾病致病基因分析研究
基本信息
- 批准号:12307034
- 负责人:
- 金额:$ 19.09万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
there are a many common disease in the genitourinary tract organ. For example, urinary tract calculi (uric acid or, oxalic acid calcium calculi), BHP, the anormalies in infant urinary tract and in male sex organs, the genitourinary tract cancer, and male sterility are such kinds of disease. It is difficult to explain such kinds of diseases as single gene diseases such as recessive or dominant hereditary diseases. These are regarded as multifactor diseases. The causative genes in these diseases are not known yet. It is important for us to accumulate DNA from the organs or blood DNA in such patients. It is also essential to analyze single nucleotide polymorphism (SNP) of candidate gene from accumulated DNA. In the present study we selected some among such kinds of common disease and accumulated DNAs from such patients. We tried to collect the 300 DNAs from the diseases such as BPH, urine tract calculi, genitourinary tract cancer (prostatic cancer, urothelial cancer, kidney cancer, germ cell tumor), We also performed DNA microarray analyses with some study designs for such diseases in order to select candidate gene groups. If causative genes are detected and new idea for the treatment is elucidated in urinary tract calculi, BPH, urinary tract anormalv in infancy and male sex organs, the genitourinary tract cancer, future foundations for the urology are established and further advances for clinical diagnosis and treatment become possible.Blood DNAs are collected in patients with 150 of kidney cancers, 46 of germ cell tumnrs 273 of prostatic cancers, 276 of tumors in the urinary bladder, 141 of PBH, 129 of urine tract calculi, 28 of hypospadia, 9 of VUR, other 56 diseases, and 37 of normality person. Total number reachs to 1145 in this project. We were able to search some candidate genes in DNA microarray analyses in some study designs. Each members also performed a study with their own study project and got some result.
泌尿生殖道器官有许多常见病。如尿路结石(尿酸或草酸钙结石)、必和必拓、婴幼儿尿路及男性性器官异常、泌尿生殖道癌、男性不育症等。单基因疾病如隐性遗传病或显性遗传病很难解释。这些被认为是多因素疾病。这些疾病的致病基因尚不清楚。从这些病人的器官或血液中积累DNA对我们来说很重要。从积累的DNA中分析候选基因的单核苷酸多态性(SNP)也是必要的。在本研究中,我们从这些常见疾病中选择了一些,并从这些患者中积累了dna。我们试图收集来自前列腺增生、尿路结石、泌尿生殖系统癌(前列腺癌、尿路上皮癌、肾癌、生殖细胞瘤)等疾病的300个DNA,并对这些疾病的一些研究设计进行DNA微阵列分析,以选择候选基因群。如果能在尿路结石、BPH、婴幼儿尿路异常及男性性器官、泌尿生殖道癌中发现致病基因,阐明新的治疗思路,为今后泌尿外科奠定基础,进一步推进临床诊疗提供可能。收集了150例肾癌患者、46例生殖细胞瘤患者、273例前列腺癌患者、276例膀胱肿瘤患者、141例PBH患者、129例尿路结石患者、28例尿道下裂患者、9例VUR患者及其他56例疾病患者、37例正常人的血液dna。本项目总数量达到1145人。在一些研究设计中,我们能够在DNA微阵列分析中搜索一些候选基因。每个成员还对自己的研究项目进行了研究,并取得了一些成果。
项目成果
期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inoue K: "The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy"Clin Cancer Res. 6(12). 4866-4873 (2000)
Inoue K:“血管生成因子表达对预测膀胱癌新辅助化疗和根治性膀胱切除术后复发和转移的预后价值”Clin Cancer Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kuroda N: "Expression of CD9/molitality-related protein 1(MRP・1) in renal parenchymal neoplasms"Hum pathol. 32(10). 1071-1010 (2001)
Kuroda N:“肾实质肿瘤中 CD9/流动相关蛋白 1(MRP·1)的表达”Hum pathol 32(10)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Habuchi T, Ogawa O, et al.: "Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect"Cancer Res. 60. 5710-5713 (2000)
Habuchi T、Okawa O 等人:“前列腺癌和良性前列腺增生的风险增加与具有基因剂量效应的 CYP17 基因多态性相关”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Guo L: "The complementary role of beta-catenin in diagnosing various subtypes of renal cell carcinomas and its up-regulation in conventional renal cell carcinomas with high noclear grades"Oncol Rep. 8(3). 521-526 (2001)
郭L:“β-连环蛋白在诊断肾细胞癌各种亚型中的互补作用及其在高级别肾细胞癌中的上调”Oncol Rep. 8(3)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kondo K, Hosaka M, et al.: "Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma : relationship to clinicopathological parameters"Genes Chromosome Cancer. 34(1). 58-68 (2002)
Kondo K、Hosaka M 等人:“散发性肾细胞癌中 VHL 基因的综合突变分析:与临床病理学参数的关系”基因染色体癌症。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHUIN Taro其他文献
SHUIN Taro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHUIN Taro', 18)}}的其他基金
Development of laminin-gamma2 monomer as a potent biomarker for upper urinary tract cancer
开发层粘连蛋白-γ2单体作为上尿路癌的有效生物标志物
- 批准号:
17K11144 - 财政年份:2017
- 资助金额:
$ 19.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical development of early detection method for renal cell carcinoma with serum cancer markers and methylated DNA-fragment cancer markers
血清癌标志物和甲基化DNA片段癌标志物肾细胞癌早期检测方法的临床开发
- 批准号:
19390417 - 财政年份:2007
- 资助金额:
$ 19.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic Strategy for the treatment of kidney cancer : identification and clinical utilization of new tumor suppressor genes or oncogenes closely correlated with VHL gene VHL
肾癌治疗的基本策略:与VHL基因密切相关的新抑癌基因或癌基因的鉴定及临床利用
- 批准号:
16390465 - 财政年份:2004
- 资助金额:
$ 19.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation in the mechanism of human renal cell carcinoma cancer growth and micrometastasis with inactivation of VHL
阐明 VHL 失活后人肾细胞癌生长和微转移的机制
- 批准号:
14370515 - 财政年份:2002
- 资助金额:
$ 19.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular detection of kidney cancers with VHL gene mutation in the blood, urine or lymph node
血液、尿液或淋巴结中 VHL 基因突变肾癌的分子检测
- 批准号:
11557118 - 财政年份:1999
- 资助金额:
$ 19.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
VHL tumor suppressor gene : Identification its function for cell growth inhibition and cell ular apoptosis for kidne cancer to develop new modality of treatment
VHL抑癌基因:鉴定其对肾癌细胞生长抑制和细胞凋亡的功能,以开发新的治疗方式
- 批准号:
09470348 - 财政年份:1997
- 资助金额:
$ 19.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
In vitro expression of von Hippel-Lindau tumor suppressor gene in human renal cell carcinoma by Herpes simplex virus vector
单纯疱疹病毒载体在人肾细胞癌中体外表达von Hippel-Lindau抑癌基因
- 批准号:
07557105 - 财政年份:1995
- 资助金额:
$ 19.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Anew trial of Genetic dlagnosisand treatment of kidney cancer based on the abnormallty in the oncogene and tumor suppressor gene Head invastigator ; Registered invastigators : Resgistered
基于癌基因和抑癌基因Head invastigator异常的肾癌基因诊断和治疗的新尝试;
- 批准号:
05671330 - 财政年份:1993
- 资助金额:
$ 19.09万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)














{{item.name}}会员




